Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Vicore Pharma Holding

9.81 SEK

-2.68 %

Less than 1K followers

VICO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vicore Pharma Holding

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue5.1109.40.91.80.80.43.8
EBITDA-60.1-83.9-184.0-91.6-111.2-116.0-133.7-452.4
EBIT-60.1-94.1-194.2-91.6-111.2-116.0-133.7-452.4
EBIT-%-1,841.1 %-177.6 %-10,286.5 %-6,352.6 %-15,258.3 %-31,911.0 %-11,851.9 %
Profit before taxes-60.0-84.1-168.9-111.5-115.4-113.5-137.1-477.5
Net income-60.0-84.1-168.6-111.5-115.4-113.5-137.1-477.5
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.